Doctor profile · Federal record
Dr. NAIMA ZAHEER, MD
Infectious Disease Physician (CMS: INFECTIOUS DISEASE) · LAS VEGAS, NV
- NPI 1447412192
- Accepts Medicare
- MIPS 13.5 / 100 · 2023
- 30 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3006 S MARYLAND PKWY, SUITE 780
LAS VEGAS, NV 891092292
(586) 482-8046
fax (702) 737-1402
Credentials & registration
- NPI registered
- June 2008 — 18 yrs on file
- Profile last updated
- March 2, 2023
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207RI0200X — NUCC code
- State license (1)
- Nevada #12736
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1447412192. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
212,813
Distinct HCPCS
10
Medicare allowed
$475,163
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0878 |
Injection, daptomycin, 1 mg | 205,461 | 11 | $0 | |
J0696 |
Injection, ceftriaxone sodium, per 250 mg | 1,834 | 11 | $1 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 1,330 | 215 | $78 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 979 | 110 | $125 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 868 | 240 | $118 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 745 | 34 | $64 | |
96366 |
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 734 | 34 | $20 | |
J1335 |
Injection, ertapenem sodium, 500 mg | 417 | 15 | $13 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 262 | 239 | $172 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 118 | 60 | $88 |
In context: peer comparison
Among 21 peers in this city , average services per provider: 3,511. This provider delivers 61× the peer median.Open Payments
Industry payments received
All-time total
$967
Transactions
35
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ViiV Healthcare Company | 10 | $219.74 | |
| Melinta Therapeutics, LLC | 3 | $151.45 | |
| Kiniksa Pharmaceuticals International, plc | 1 | $117.89 | |
| Merck Sharp & Dohme LLC | 5 | $115.27 | |
| Insmed, Inc. | 3 | $83.89 | |
| Regeneron Healthcare Solutions, Inc. | 3 | $76.43 | |
| Gilead Sciences, Inc. | 3 | $63.42 | |
| ABBVIE INC. | 2 | $40.50 | |
| Electromed, Inc. | 2 | $35.75 | |
| Grifols USA, LLC | 1 | $26.61 | |
| Astellas Pharma US Inc | 1 | $22.77 | |
| Napo Pharmaceuticals Inc | 1 | $13.19 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
936
Patients
364
Total drug cost
$693,821
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Daptomycin | Generic | 187 | 50 | $382,367 |
| Cefepime Hcl | Generic | 135 | 47 | $31,611 |
| Ceftriaxone (Ceftriaxone Sodium) | Brand | 86 | 33 | $8,597 |
| Doxycycline Hyclate | Generic | 79 | 41 | $1,983 |
| Cefdinir | Generic | 63 | 42 | $2,135 |
| Ertapenem (Ertapenem Sodium) | Brand | 54 | 22 | $43,937 |
| Linezolid | Generic | 52 | 29 | $6,871 |
| Vancomycin Hcl | Generic | 51 | 15 | $4,258 |
| Biktarvy (Bictegrav/Emtricit/Tenofov Ala) | Brand | 46 | 0 | $195,033 |
| Cefuroxime (Cefuroxime Axetil) | Brand | 42 | 26 | $1,608 |